Post-approval Registry Study to Evaluate the Continued Safety and Probable Benefit of the MID-C System for 5 Years Post-Implantation in Adolescent Idiopathic Scoliosis (AIS)

NAActive, not recruitingINTERVENTIONAL
Enrollment

201

Participants

Timeline

Start Date

May 31, 2020

Primary Completion Date

June 30, 2029

Study Completion Date

June 30, 2030

Conditions
Adolescent Idiopathic Scoliosis
Interventions
DEVICE

MID-C System

Minimal invasive deformity correction system for the treatment of AIS

Trial Locations (14)

10029

Mount Sinai hospital, New York

22903

University of Virginia, Charlottesville

30060

Wellstar, Atlanta

32207

Wolfson children's hospital, Jacksonville

39216

Univ. of Mississippi Medical Center (UMMC), Jackson

44106

Rainbow babies and children, Cleveland

45404

Dayton Children's Hospital, Dayton

46202

Riley Children's Health, Indianapolis

55902

Mayo Clinic, Rochester

57105

Avera Health, Sioux Falls

63110

Shriners Hospitals for Children, St Louis

64108

Children's Mercy Hospital, Kansas City

65201

Women and Children's Hospital - University of Missouri Health Care, Columbia

92123

Rady Children's Hospital, San Diego

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Apifix

INDUSTRY

NCT04296903 - Post-approval Registry Study to Evaluate the Continued Safety and Probable Benefit of the MID-C System for 5 Years Post-Implantation in Adolescent Idiopathic Scoliosis (AIS) | Biotech Hunter | Biotech Hunter